14 feb: Gabriel-topchef er klar på nyt opkøb
14 feb: Shipping: Baltic Dry-indekset falder 0,4 pct. til 685 point
14-02-2017 14:01:41

Trading in Novo Nordisk shares by board members, executives and associated persons on 9 February and 13 February 2017

Relateret indhold
21 jul - 
Fredagens aktier: Mærsk, Novo og FLSmidth sendte C20 ti..
18 jul - 
Tirsdagens aktier: Gevinst til Mærsk kunne ikke hindre ..
18 jul - 
Aktier/middag: TDC og Mærsk topper rekordstemt C20 Cap
Relateret debat
21 jul - 
-1,73% 
21 jul - 
helt sygt den kal falde så meget, forventer den e..
21 jul - 
Der har ikke været en "god" Novo nyhed i rigtig lang ti..

Bagsværd, Denmark, 14 February 2017 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. 

 

The company's board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company's board members, executives and their associated persons. 

 

Definitions and background information:

 

Publication

Publication shall take place no later than three working days after the trading by board members, executives or their associated persons. Publication is only required when the total amount of transactions of a specific board member/executive and his/her associated persons in any one calendar year has reached 20,000 EUR. 

 

Who are board members, executives and associated persons?

Board members and executives are members of the Board of Directors and Executive Management, respectively, of Novo Nordisk A/S. Associated persons are defined as the following persons associated to a board member/executive: 1) spouse or cohabitant, 2) children under the age of 18 years, 3) Other relatives defined as brothers, sisters, parents, grandparents, children, grandchildren, cousins etc. who have shared the same household with a board member or executive for a period of at least one year on the date of the given transaction and 4) any legal persons, trust, or partnership, the managerial responsibilities of which are discharged by a board member/executive or by a person referred to in items 1)-3) above, which is directly or indirectly controlled by such a person, which is set up for the benefit of such a person, or the economic interests of which are substantially equivalent to those of such a person. 

 

What is trading/transaction?

Trading is any kind of transaction, including shares and share related securities purchased or otherwise acquired, sold or otherwise disposed, gifts, mortgages, heritage and grants, allotments and exercise of options. 

 

What is financial instrument and ID code? 

Financial instrument includes shares listed on the Nasdaq Copenhagen and ADRs listed on New York Stock Exchange, except for ADRs held in 401(k) retirement plan by US-based employees. The ID code is the code (ISIN DK0060534915) of the Novo Nordisk share on the Nasdaq Copenhagen or the code (NVO) on New York Stock Exchange.

 

What is date and place of transaction?

Date of transaction is the actual transaction date. The place of transaction is the actual place of transaction, i.e. Nasdaq Copenhagen or New York Stock Exchange.

 

What is the volume and price of transaction and aggregated information?

The volume of transaction is the number of shares (of DKK 0.20 nominal value) or other financial instruments traded. In case of a single transaction the price is the price of that single transaction. In case of multiple transactions, when the transactions relates to the same financial instrument, are of the same nature, are executed on the same day and are executed on the same place, the volume must be aggregated. The price of the aggregated transactions is the weighted average price. 

 

The exchange rate of the Danish Central Bank (Nationalbanken) on the date of transaction is used for calculating the transaction value in DKK in case of ADRs listed on New York Stock Exchange.

Further information

Media:

 

 

Anne Margrethe Hauge

+45 4442 3450

amhg@novonordisk.com

Ken Inchausti (US)

+1 609 514 8316

kiau@novonordisk.com

 

 

 

Investors:

 

 

Peter Hugreffe Ankersen

+45 3075 9085

phak@novonordisk.com

Hanna Ögren

+45 3079 8519

haoe@novonordisk.com

Anders Mikkelsen

+45 3079 4461

armk@novonordisk.com

Kasper Veje (US)

+1 609 235 8567

kpvj@novonordisk.com

Company announcement No 11 / 2017

Company announcement No 11 / 2017


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Globenewswire

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
20 jul
NOVO-B
Vi nærmer os med (pt.) små skridt Q2-2017, og mon ikke det spiller lidt ind på NOVO kursen ??   Jeg ..
3
21 jul
NOVO-B
Det var blot en konstatering af, at indtil nu, har der ikke være en GLP-1 , bortset fra Liraglutide/..
1
20 jul
NOVO-B
Næste super nyhed er når Semaglutide vs Trulicity data præsenteres, det skulle vist være i dette kva..
1
20 jul
NOVO-B
Nå - jeg vidste ikke, at Novo Nordisk havde fået ny CEO. I morges hed han Lars til fornavn lige som ..
1
17 jul
NOVO-B
Han bruger modsat konkurrenten, super insulinen Tresiba, der nedsætter hypoglykæmi med 85% til 92% i..
1
17 jul
NOVO-B
Fra Wiki: "As part of his ongoing treatment he wears a wireless blood sugar monitor and carries sug..
1

GE Wind solgte igen færre vindmøller i andet kvartal

21-07-2017 13:02:07
General Electric (GE) havde igen et fald i antallet af bestilte og afskibede vindmøller i andet kvartal i GE Wind-forretningen, der er en af Vestas' store konkurrenter.GE Winds ordreindgang faldt til 567 møller fra 637 i samme kvartal for et år siden, og der blev sendt 757 afsted til kunderne mod 856 i andet kvartal af 2016.Det var andet kvartal i træk med fald i ordrerne og tredje i træk med et l..

Aktier/middag: FLSmidth får stryg og tager bunden i C20

21-07-2017 11:42:46
FLSmidth er under pres på et positivt dansk aktiemarked, der fredag er præget af sommerferie med begrænset volumen og nyhedsstrøm.Den danske ingeniørkoncern er i fokus, da den finske rival Metso har offentliggjort et svagt regnskab for andet kvartal, hvor driftsoverskuddet på 59,8 mio. euro var et stykke fra det ventede plus på 78 mio. euro.Et positivt element var dog, at forventningerne til efter..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas henter amerikansk ordre på 200 MW - NY
2
Fredagens aktier: Mærsk, Novo og FLSmidth sendte C20 til tælling
3
Aktier/middag: FLSmidth får stryg og tager bunden i C20
4
Danske Bank/Jyske: Tror stadig på større overskud end banken selv
5
Dansk økonom udpeget til topstilling i fransk storbank

Relaterede aktiekurser

Novo Nordisk B A/S 273,30 -1,7% Fald i aktiekurs
Novo Nordisk 41,25 1,9% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. juli 2017 08:45:36
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170720.2 - EUROWEB1 - 2017-07-22 08:45:36 - 2017-07-22 08:45:36 - 1 - Website: OKAY